Andres
Iñiguez Romo
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublications in collaboration with researchers from Icahn School of Medicine at Mount Sinai (17)
2021
-
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent
Catheterization and Cardiovascular Interventions, Vol. 98, Núm. 3, pp. 503-510
-
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 2, pp. 309-320
-
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 797-804
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041
2020
-
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry
IJC Heart and Vasculature, Vol. 31
-
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration
Cardiovascular Revascularization Medicine, Vol. 21, Núm. 12, pp. 1542-1547
-
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration
International Journal of Cardiology, Vol. 307, pp. 17-23
-
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)
American Journal of Cardiology, Vol. 127, pp. 1-8
2019
-
Corrigendum to “Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry” [Int. J. Cardiol. 283 (2019) 67–72](S0167527318318412)(10.1016/j.ijcard.2019.01.053)
International Journal of Cardiology
-
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry
International Journal of Cardiology, Vol. 283, pp. 67-72
2018
-
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration
JACC: Cardiovascular Interventions, Vol. 11, Núm. 19, pp. 1969-1978
2014
-
Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study
JACC: Cardiovascular Imaging, Vol. 7, Núm. 4, pp. 397-405
-
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)
Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362
-
Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"
Circulation
2013
-
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial
Circulation, Vol. 128, Núm. 14, pp. 1495-1503
2012
-
Study design for the effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion (METOCARD-CNIC): A randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction
American Heart Journal, Vol. 164, Núm. 4
2011
-
Modulation of the beta-adrenergic system during acute myocardial infarction: Rationale for a new clinical trial
Revista Espanola de Cardiologia, Vol. 64, Núm. SUPPL. 2, pp. 28-33